Kelly CRISPR & Gene Editing Technology ETF (XDNA)

Assets	$2.10M
Expense Ratio	0.78%
PE Ratio	17.02
Shares Out	n/a
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Ratio	n/a
1-Year Return	n/a

Volume	4,251
Open	7.53
Previous Close	7.50
Day's Range	7.38 - 7.55
52-Week Low	5.87
52-Week High	11.83
Beta	n/a
Holdings	3
Inception Date	Jan 12, 2022

About XDNA

Fund Home Page

The Kelly CRISPR & Gene Editing Technology ETF (XDNA) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market-cap-weighted index of companies in developed markets that focus on the advancements in DNA modification technology. XDNA was launched on Jan 12, 2022 and is issued by Kelly.

• Asset Class: Equity
• Category: Health
• Stock Exchange: NASDAQ
• Ticker Symbol: XDNA
• ETF Provider: Kelly
• Index Tracked: Strategic CRISPR & Gene Editing Technology Index